Trial Profile

An Open-Label Clinical Study of the Safety and Efficacy of RPH-104 in Preventing Recurrences in Patients With Idiopathic Recurrent Pericarditis

Status: Active, no longer recruiting

Phase of Trial: Phase III

Latest Information Update: 08 Nov 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Goflikicept (Primary)
Indications Pericarditis
Focus Adverse reactions
Sponsors R-Pharm

Most Recent Events

31 Oct 2023 Planned End Date changed from 1 Aug 2024 to 1 Jan 2026.
31 Oct 2023 Planned primary completion date changed from 1 Aug 2024 to 1 Jan 2026.
09 Jan 2023 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com